Literature DB >> 20853674

Molecular detection of virulence factors and antibiotic resistance pattern in clinical Enterococcus faecalis strains in Sardinia.

S Cosentino1, G S Podda, A Corda, M E Fadda, M Deplano, M B Pisano.   

Abstract

In this study, the antibiotic resistance pattern and the presence of genes encoding several virulence factors in 91 Enterococcus faecalis strains isolated from different human clinical sources in Sardinia were investigated. Genotypic determination of virulence genes (gelE, esp, agg, ace, cylA,B,M,L(L),L(S), efaA, fsrB) was carried out by PCR. The production of gelatinase and haemolytic activity were also determined. Antimicrobial susceptibility tests were performed by an automated microdilution test (Vitek). The strains examined in this study contained at least one and up to as many as all virulence genes investigated. Examining the distribution of these factors in the different groups of clinical strains, we found that all but one virulence determinant were detected more frequently among urinary isolates. The detection of some factors by PCR did not always correlate with its phenotypic expression. Antibiotic susceptibilities among the Enterococcus faecalis strains investigated in our study were typical for the species, with expected levels of acquired resistance. Faecal isolates had the highest percentage of resistance, especially to high level-gentamicin, ciprofloxacin and norfloxacin. In summary, a wide variety of genes encoding virulence factors have been detected among our clinical Enterococcus faecalis strains, and those isolated from UTI were characterized by a higher virulence potency compared with strains from other clinical sources. Silent virulence genes (cyl or gelE) were frequently detected, therefore both the genotypic and phenotypic assays seem necessary for a better characterization of the strains. Our results may serve as a basis for additional surveillance studies of infections caused by this microorganism.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20853674

Source DB:  PubMed          Journal:  J Prev Med Hyg        ISSN: 1121-2233


  7 in total

1.  Virulence and antimicrobial resistance in enterococci isolated from urinary tract infections.

Authors:  Yaeghob Sharifi; Alka Hasani; Reza Ghotaslou; Behrouz Naghili; Mohammad Aghazadeh; Mortaza Milani; Ahad Bazmany
Journal:  Adv Pharm Bull       Date:  2013-02-07

2.  Draft Genome Sequence of the Nonstarter Bacteriocin-Producing Strain Enterococcus mundtii CRL35.

Authors:  Julieta Bonacina; Lucila Saavedra; Nadia E Suárez; Fernando Sesma
Journal:  Genome Announc       Date:  2014-05-22

3.  Genetic relatedness of the Enterococcus faecalis isolates in stool and urine samples of patients with community-acquired urinary tract infection.

Authors:  Zohreh Ghalavand; Masoud Alebouyeh; Kiandokht Ghanati; Leila Azimi; Marjan Rashidan
Journal:  Gut Pathog       Date:  2020-09-09       Impact factor: 4.181

4.  Draft Genome Sequence of Enterococcus faecium Strain CRL 1879, Isolated from a Northwestern Argentinian Artisanal Cheese.

Authors:  Nadia E Suárez; Lucila Saavedra; Ivana Slozilová; Julieta Bonacina; Katerina Demnerová; Fernando Sesma
Journal:  Genome Announc       Date:  2013-07-18

5.  Molecular detection of virulence factors among food and clinical Enterococcus faecalis strains in South Brazil.

Authors:  A W Medeiros; R I Pereira; D V Oliveira; P D Martins; P A d'Azevedo; S Van der Sand; J Frazzon; A P G Frazzon
Journal:  Braz J Microbiol       Date:  2014-04-18       Impact factor: 2.476

6.  Prevalence and Genetic Diversity of Enterococcus faecalis Isolates from Mineral Water and Spring Water in China.

Authors:  Lei Wei; Qingping Wu; Jumei Zhang; Weipeng Guo; Moutong Chen; Liang Xue; Juan Wang; Lianying Ma
Journal:  Front Microbiol       Date:  2017-06-16       Impact factor: 5.640

7.  Incidence of virulence determinants in clinical Enterococcus faecalis and Enterococcus faecium isolates collected in Bulgaria.

Authors:  Tanya Strateva; Daniela Atanasova; Encho Savov; Guergana Petrova; Ivan Mitov
Journal:  Braz J Infect Dis       Date:  2016-02-02       Impact factor: 3.257

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.